Showing: 1 - 1 of 1 RESULTS
Biotech Briefing COVID-19 Psychedelics Revive Therapeutics

Revive Submits for IRB Approval; Expects to Enroll Patients in September

This morning Revive Therapeutics (CSE: RVV, USA: RVVTF) announced they have submitted a clinical trial protocol to their independent Institutional Review Board (IRB) for approval. The company also announced they expect to have patients enrolled in September 2020. What is an IRB? An institutional review board is an appropriately constituted group that has been formally designated …